Novartis Pharmaceuticals Corporation V. Cipla Limited - 1:25-cv-00186

Novartis Pharmaceuticals Corporation V. Cipla Limited (Case No. 1:25-cv-00186), filed on Feb 14, 2025 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:25-cv-00186
Filing Date
Feb 14, 2025
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Cipla Limited -
Novartis AG -

Patents Involved

This case involves 3 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US12071402B2
-US8492441B2
-US11944602B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Feb 14, 2025Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis AG, Novartis Pharmaceuticals Corporation. (oam) (Entered: 02/14/2025)PACER Document
Feb 14, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,492,441; 11,944,602; 12,071,402. (oam) (Entered: 02/14/2025)PACER Document
Feb 14, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached. (oam) (Entered: 02/14/2025)PACER Document
Feb 14, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 02/14/2025)PACER Document
Feb 14, 2025COMPLAINT against Cipla Limited and Cipla USA, Inc. (Filing fee $ 405, receipt number ADEDC-4615434) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibits A-C, # 2 Civil Cover Sheet)(oam) (Entered: 02/14/2025)PACER Document
Feb 14, 2025COMPLAINT against Cipla Limited and Cipla USA, Inc. (Filing fee $ 405, receipt number ADEDC-4615434) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibits A-C, # 2 Civil Cover Sheet)(oam) (Entered: 02/14/2025)Attachment
Feb 14, 2025No Summons Issued. (oam)PACER Document
Feb 14, 2025COMPLAINT against Cipla Limited and Cipla USA, Inc. (Filing fee $ 405, receipt number ADEDC-4615434) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibits A-C, # 2 Civil Cover Sheet)(oam) (Entered: 02/14/2025)Attachment